Literature DB >> 6966551

Histamine suppression of lymphocyte activation.

J Brostoff, S Pack, P M Lydyard.   

Abstract

Histamine suppresses lymphocyte transformation induced by the mitogen Con A. The effect is dose-related and is not blocked by H1 or H2 antagonists. High dose of H2 antagonists (10(-3) M) enhances the suppression induced by histamine. The proliferation of T cells alone cultured with histamine is suppressed indicating that histamine can exert its effect directly on T cell proliferation without the requirement for accessory cells. Atopic subjects are more sensitive to histamine-induced suppression than normals. The presence of histamine produced locally during a Type I response may provide a mechanism for preventing the proliferation of sensitized T cells which enter the site of antigen stimulation. In the atopic, who already has the immunological machinery to mount cell-mediated immune responses to pollens, this increased histamine sensitivity may be protective in suppressing unwanted delayed hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966551      PMCID: PMC1538129     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Fixation of tuberculin in the skin of tuberculin sensitive human subjects.

Authors:  J PEPYS
Journal:  Clin Sci       Date:  1955-05       Impact factor: 6.124

2.  Histamine-receptor leucocytes (HRL). Organ and lymphoid subpopulation distribution in man.

Authors:  A Saxon; V D Morledge; B Bonavida
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Induction of both reaginic and blocking antibodies with a low molecular weight fraction of timothy pollen extract.

Authors:  A Malley; F Perlman
Journal:  J Allergy       Date:  1969-02

4.  Cell-mediated (delayed) hypersensitivity in patients with summer hay-fever.

Authors:  J Brostoff; I M Roitt
Journal:  Lancet       Date:  1969-12-13       Impact factor: 79.321

5.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

6.  Inhibition of guinea-pig lymphocyte activation by histamine and histamine analogues.

Authors:  J L Beets; M M Dale
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

7.  Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma.

Authors:  A A Mathé; P Hedqvist; A Holmgren; N Svanborg
Journal:  Br Med J       Date:  1973-01-27

8.  Increased sensitivity of lymphocytes from atopic individuals to histamine-induced suppression.

Authors:  I L Strannegård; O Strannegård
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation.

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  12 in total

1.  Quantitative aspects of the T cell proliferation response to antigen P1 from D. pteronyssinus: suppression by added histamine and limited effects of basophil depletion.

Authors:  F C Rawle; T A Platts-Mills; E B Mitchell
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

2.  Experimental dermatophytosis in mice: correlation between light and electron microscopic changes in primary, secondary and chronic infections.

Authors:  R J Hay; R A Calderon; C D Mackenzie
Journal:  Br J Exp Pathol       Date:  1988-10

3.  Histamine-induced inhibition of lymphocyte proliferation and lysosomal enzyme release from polymorphs may not be mediated via H1- or H2-receptors.

Authors:  M R Vickers; K Milliner; D Martin; C R Ganellin
Journal:  Agents Actions       Date:  1982-12

4.  Chemiluminescence response of human blood mononuclear cells to PHA and histamine.

Authors:  K Merétey; U Böhm; A Falus
Journal:  Agents Actions       Date:  1983-04

5.  Inhibition of lymphocyte proliferation by histamine and related compounds not mediated via H1- or H2- receptors.

Authors:  D Gordon; G P Lewis; A M Nouri
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

6.  Peripheral blood T lymphocytes in patients with duodenal ulcers treated with cimetidine.

Authors:  M R Gigi; E Akriviadis; I Agorastos; G Goulis
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Acyltryptophols reversibly inhibit the uptake of thymidine after phytohaemagglutinin transformation of human lymphocytes.

Authors:  A Moshtaghfard; I Smith
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

8.  Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to favour histamine tissue diffusion through mixed-ligand coordination. In vitro tests on lymphocyte proliferation.

Authors:  G Berthon; A Varsamidis; C Blaquiere; D Rigal
Journal:  Agents Actions       Date:  1987-12

9.  Modulation of human natural killer cell activity by pharmacological mediators.

Authors:  T J Hall; S H Chen; J Brostoff; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

10.  Inhibition of phytohaemagglutinin-induced proliferation of human peripheral blood lymphocytes by histamine and histamine H1 and H2 agonists.

Authors:  A M Badger; J Young; G Poste
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.